These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32508359)

  • 41. Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).
    van der Does Y; Limper M; Jie KE; Schuit SCE; Jansen H; Pernot N; van Rosmalen J; Poley MJ; Ramakers C; Patka P; van Gorp ECM; Rood PPM
    Clin Microbiol Infect; 2018 Dec; 24(12):1282-1289. PubMed ID: 29870855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of procalcitonin testing to a targeted audit-and-feedback strategy on prescribed durations of therapy for community-acquired pneumonia.
    Clark LT; Beuschel TS; Buss PM; Jameson AP; Dumkow LE
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115202. PubMed ID: 33007583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis.
    Kip MM; Kusters R; IJzerman MJ; Steuten LM
    J Med Econ; 2015; 18(11):944-53. PubMed ID: 26105574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
    Stocker M; Fontana M; El Helou S; Wegscheider K; Berger TM
    Neonatology; 2010; 97(2):165-74. PubMed ID: 19776651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical pulmonary infection score and a spot serum procalcitonin level to guide discontinuation of antibiotics in ventilator-associated pneumonia: a study in a single institution with high prevalence of nonfermentative gram-negative bacilli infection.
    Wongsurakiat P; Tulatamakit S
    Ther Adv Respir Dis; 2018; 12():1753466618760134. PubMed ID: 29506460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Procalcitonin: Is This the Promised Biomarker for Critically Ill Patients?
    Fontela PS; Lacroix J
    J Pediatr Intensive Care; 2016 Dec; 5(4):162-171. PubMed ID: 31110901
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States.
    Balk RA; Kadri SS; Cao Z; Robinson SB; Lipkin C; Bozzette SA
    Chest; 2017 Jan; 151(1):23-33. PubMed ID: 27568580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin.
    Watkins AB; Van Schooneveld TC; Reha CG; Anderson J; McGinnis K; Bergman SJ
    Pharmacy (Basel); 2021 Aug; 9(3):. PubMed ID: 34449706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials.
    Wirz Y; Meier MA; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Schroeder S; Nobre V; Annane D; Reinhart K; Damas P; Nijsten M; Shajiei A; deLange DW; Deliberato RO; Oliveira CF; Shehabi Y; van Oers JAH; Beishuizen A; Girbes ARJ; de Jong E; Mueller B; Schuetz P
    Crit Care; 2018 Aug; 22(1):191. PubMed ID: 30111341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-Effectiveness Analysis of a Procalcitonin-Guided Decision Algorithm for Antibiotic Stewardship Using Real-World U.S. Hospital Data.
    Voermans AM; Mewes JC; Broyles MR; Steuten LMG
    OMICS; 2019 Oct; 23(10):508-515. PubMed ID: 31509068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of Procalcitonin-Guided Antibiotic Management on Antibiotic Exposure and Outcomes: Real-world Evidence.
    Broyles MR
    Open Forum Infect Dis; 2017; 4(4):ofx213. PubMed ID: 29164170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial.
    Maravić-Stojković V; Lausević-Vuk L; Jović M; Ranković A; Borzanović M; Marinković J
    Srp Arh Celok Lek; 2011; 139(11-12):736-42. PubMed ID: 22338468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial.
    Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Dubois J; Marti J; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N
    BMC Pulm Med; 2019 Aug; 19(1):143. PubMed ID: 31387559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature.
    Covington EW; Roberts MZ; Dong J
    Pharmacotherapy; 2018 May; 38(5):569-581. PubMed ID: 29604109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Procalcitonin-guided antibiotic therapy: an expert consensus.
    Bartoletti M; Antonelli M; Bruno Blasi FA; Casagranda I; Chieregato A; Fumagalli R; Girardis M; Pieralli F; Plebani M; Rossolini GM; Sartelli M; Viaggi B; Viale P; Viscoli C; Pea F
    Clin Chem Lab Med; 2018 Jul; 56(8):1223-1229. PubMed ID: 29874192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.
    Collins CD; Brockhaus K; Sim T; Suneja A; Malani AN
    Am J Health Syst Pharm; 2019 Aug; 76(16):1219-1225. PubMed ID: 31369118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials.
    Meier MA; Branche A; Neeser OL; Wirz Y; Haubitz S; Bouadma L; Wolff M; Luyt CE; Chastre J; Tubach F; Christ-Crain M; Corti C; Jensen JS; Deliberato RO; Kristoffersen KB; Damas P; Nobre V; Oliveira CF; Shehabi Y; Stolz D; Tamm M; Mueller B; Schuetz P
    Clin Infect Dis; 2019 Jul; 69(3):388-396. PubMed ID: 30358811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum Procalcitonin as a Biomarker to Determine the Duration of Antibiotic Therapy in Adult Patients with Sepsis and Septic Shock in Intensive Care Units: A Prospective Study.
    Vishalashi SG; Gupta P; Verma PK
    Indian J Crit Care Med; 2021 May; 25(5):507-511. PubMed ID: 34177168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Introduction of Procalcitonin Testing and Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Ulrich RJ; McClung D; Wang BR; Winters S; Flanders SA; Rao K
    Infect Dis (Auckl); 2019; 12():1178633719852626. PubMed ID: 31223234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimizing Prophylactic Antibiotic Practice for Cardiothoracic Surgery by Pharmacists' Effects.
    Zhou L; Ma J; Gao J; Chen S; Bao J
    Medicine (Baltimore); 2016 Mar; 95(9):e2753. PubMed ID: 26945362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.